They noted that KRASIM is expressed at lower levels in HCC compared to normal hepatocytes and found that it inhibits HCC cell growth and proliferation by reducing KRAS protein levels and dampening ERK signaling pathway activity [70]. This evidence concerns the gene KRAS and hepatocellular carcinoma.